Lv6
1730 积分 2024-03-04 加入
FDA Approval Summary: Oral Azacitidine for Continued Treatment of Adults with Acute Myeloid Leukemia Unable to Complete Intensive Curative Therapy
1小时前
待确认
Long‐term survival with oral azacitidine for patients with acute myeloid leukemia in first remission after chemotherapy: Updated results from the randomized, placebo‐controlled, phase 3 QUAZAR AML‐001 trial
1小时前
待确认
Post-HCT maintenance therapy for AML: who, when, why, how long?
2小时前
待确认
How I use maintenance therapy in acute myeloid leukemia
2小时前
待确认
How I treat patients with AML using azacitidine and venetoclax
1天前
待确认
How I use maintenance therapy in acute myeloid leukemia
1天前
待确认
Post-HCT maintenance therapy for AML: who, when, why, how long?
1天前
待确认
Isatuximab Subcutaneous by On-Body Delivery System vs Isatuximab Intravenous Plus Pomalidomide and Dexamethasone in Relapsed/Refractory Multiple Myeloma: Phase 3 IRAKLIA Study
2天前
已完结
Immunogenicity of biologic agents in rheumatology
5天前
已完结
Human CD38, a leukocyte receptor and ectoenzyme, is a member of a novel eukaryotic gene family of nicotinamide adenine dinucleotide+-converting enzymes: extensive structural homology with the genes for murine bone marrow stromal cell antigen 1 and aplysian ADP-ribosyl cyclase
5天前
待确认
皖公网安备34019202002308
